PPT-Subcutaneous Route for Drugs and Fluids
Author : jones | Published Date : 2022-07-15
Annette O Arthur PharmD Department of Emergency Medicine University of Oklahoma School of Community Medicine Disclosures Coinvestigator on a study funded by Halozyme
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Subcutaneous Route for Drugs and Fluids" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Subcutaneous Route for Drugs and Fluids: Transcript
Annette O Arthur PharmD Department of Emergency Medicine University of Oklahoma School of Community Medicine Disclosures Coinvestigator on a study funded by Halozyme Therapeutics the manufacturer of the FDA approved human recombinant . Administer IPV and PPSV vaccines either via IM or SQ subcutaneous route Patients age Site see illustrations Needle size Newborninfant Birth 1 year Anterolateral thigh 1 needle 58 in premies or newborns 028 days old if muscle mass inadequate 2325 Verbiage Changes. 11010 . Changes:. Debridement including removal of foreign material . associated. . with. . at the site of an. open fracture. (s). and/or . an open. dislocation. (s). (. eg, . #ACP2016: 30 Years of Leadership in Vein Care. Kenneth E. Harper, MD, FACS, . RPhS. , RPVI. Vein Specialists of the South. expect the unexpected. No conflict of interest with this lecture.. On the surface. Fluids. A fluid is anything that flows: liquids and gases. One . common characteristic is that fluids have no fixed shape and are easily . deformed: . t. ake the shape of their containers.. Density. The density of a substance is the quantity of matter contained in a unit volume of the substance. . Andrew Scordato EMT-P. Toxicology. Toxic Exposure. 10% of ED visits and EMS responses involve toxic exposures.. 70% of accidental poisonings occur in children under 6 years old.. Drug Abuse. In 2010 22.6 million. Pediatric center . Srikant Das, MD. Director, Electrophysiology and Pacing. Arkansas Children’s Hospital. Background. An entirely subcutaneous ICD system (S-ICD) avoids the need for the placement of electrodes within the heart and can provide clinical advantages especially in pediatric population. . Dr. Jwan Mohammed. Oral route . Parenteral route. Intravenous. Intramuscular. Subcutaneous. Transdermal route. Rectal route . Pulmonary route . Oral route of administration. The oral route of administration is the most convenient route for drug administration because of low production cost, better suitability for self administration, higher level of patient safety and better patient . 30 -1-2017. Dr. . Naza. M. Ali. Antifungal Drugs . . Unlike bacteria, fungi are eukaryotic.. Fungal infections are generally resistant to . . antibiotics used in the treatment of bacterial . DRUG PRICES ARE RISING AT AN UNSUSTAINABLE AND SEEMINGLY IRRATIONAL RATEAdvancements in pharmaceuticals can result in drugs that offer fewer side effects improve a patient146s quality of life and save GANGREN. By . Dr. Hussein . AlNaji. ETIOLOGY. Extensive accumulation of edema fluid in the subcutaneous tissue is part of general edema and is caused by the same diseases, as follows.. A-Increased Hydrostatic Pressure. BP=602. Pharmacology III. Asthma. Bronchial asthma is a respiratory disorder characterized by wheezing and difficulty in breathing due to increased resistance to airflow in the alveoli or small airways. This is caused by the spasm of the bronchial smooth muscles and also due to edema and swelling of bronchial mucous membrane. The viscid sputum causes blockage of small airways. . Anjana. Assistant Professor. Deptt. . of Veterinary Pharmacology & Toxicology. Bihar Veterinary College, Bihar Animal Sciences University, Patna. Overview of the chapter . Introduction (. Sedatives, Hypnotics. DB09302. Description. :. Alirocumab. is a biopharmaceutical drug approved by the FDA in July 2015 as a second line treatment for high cholesterol for adults whose LDL-cholesterol (LDL-C) is not controlled by diet and statin treatment. It is a human monoclonal antibody administered by subcutaneous injection that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety. PCSK9 inhibition facilitates more LDL-C clearance from the blood. Dr Mohamed . Awad. ST4 QE Gateshead. 30 . yrs. . male. PC:. 10/7 dyspnoea, productive . cough with left-sided pleuritic chest . pain and fever. . PMH:. Autism spectrum. F&W. Smokes cannabis.. I.
Download Document
Here is the link to download the presentation.
"Subcutaneous Route for Drugs and Fluids"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents